176.42
0.73%
1.28
Handel nachbörslich:
176.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$175.14
Offen:
$174.13
24-Stunden-Volumen:
2.59M
Relative Volume:
1.35
Marktkapitalisierung:
$79.51B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.43B
KGV:
35.86
EPS:
4.92
Netto-Cashflow:
$2.31B
1W Leistung:
+0.15%
1M Leistung:
-8.72%
6M Leistung:
+1.36%
1J Leistung:
+0.93%
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Vergleichen Sie ZTS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-01-12 | Bestätigt | Stifel | Buy |
2023-12-19 | Fortgesetzt | Jefferies | Buy |
2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
2023-09-06 | Eingeleitet | HSBC Securities | Buy |
2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
2020-05-27 | Eingeleitet | Jefferies | Buy |
2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
2019-09-09 | Eingeleitet | Goldman | Buy |
2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
2019-06-11 | Eingeleitet | Barclays | Overweight |
2019-05-23 | Eingeleitet | Guggenheim | Buy |
2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
2019-03-20 | Eingeleitet | SunTrust | Hold |
2019-03-04 | Hochstufung | Stifel | Hold → Buy |
2019-01-23 | Eingeleitet | UBS | Neutral |
2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-08-22 | Herabstufung | Stifel | Buy → Hold |
2018-08-03 | Bestätigt | Stifel | Buy |
2018-04-19 | Bestätigt | Citigroup | Buy |
2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2018-02-16 | Bestätigt | Stifel | Buy |
2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
MAI Capital Management Sells 4,871 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy (NYSE:ZTS) - Seeking Alpha
Thrivent Financial for Lutherans Sells 95,529 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Sawgrass Asset Management LLC Sells 21,530 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Sold by Vaughan Nelson Investment Management L.P. - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Bought by Comgest Global Investors S.A.S. - MarketBeat
Mizuho Securities USA LLC Has $950.52 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Natixis Advisors LLC Acquires 32,407 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Impax Asset Management Group plc Trims Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Simplify Asset Management Inc. Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Beyond Local: Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs - St. Albert Gazette
Dearborn Partners LLC Sells 3,748 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis debuts AI-powered haematology tech at London Vet Show - vet times
Pet owners report extreme alleged side effects from ‘miracle drug’ Librela for arthritic dogs - The Globe and Mail
Victory Capital Management Inc. Grows Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
What Are Wall Street Analysts' Target Price for Zoetis Stock? - MSN
What Are Wall Street Analysts' Target Price For Zoetis Stock? - Barchart
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Huntington National Bank - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by KBC Group NV - MarketBeat
Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc - GuruFocus.com
Sumitomo Mitsui Trust Group Inc. Raises Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis raises another $100K for mental health support in rural Australia - Beef Central
Zoetis Announces Major Leadership Changes for Growth - TipRanks
Aigen Investment Management LP Takes Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Ashton Thomas Private Wealth LLC Lowers Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis - AccessWire
Zoetis Inc. (NYSE:ZTS) Stake Reduced by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Zoetis Names Jamie Brannan as First Chief Commercial Officer - Swineweb.com
Zoetis Inc. (NYSE:ZTS) Shares Purchased by Waverton Investment Management Ltd - MarketBeat
GSA Capital Partners LLP Buys Shares of 11,354 Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Bought by Nations Financial Group Inc. IA ADV - MarketBeat
Zoetis Inc. (NYSE:ZTS) Shares Acquired by Chartwell Investment Partners LLC - MarketBeat
WATCH: CO Dog mayor gives ‘paw of approval’ on opening day - AOL
Phibro Animal Health completes acquisition of Zoetis’ medicated feed additive portfolio - www.thecattlesite.com
Zoetis Appoints Jamie Brannan as Chief Commercial Officer - citybiz
Zoetis reshapes leadership for global growth By Investing.com - Investing.com South Africa
Janie Slaven: PETS OF THE WEEK: Ozzy and Lizzy - AOL
Zoetis reshapes leadership for global growth - Investing.com
Zoetis appoints Jamie Brannan chief commercial officer - TipRanks
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role - The Bakersfield Californian
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role – Company Announcement - Financial Times
Zoetis Q3: Strong Osteoarthritis Pain Franchise (NYSE:ZTS) - Seeking Alpha
Zoetis Inc. (NYSE:ZTS) Shares Bought by Los Angeles Capital Management LLC - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stake Raised by Jensen Investment Management Inc. - MarketBeat
Ownership Capital B.V. Has $150.76 Million Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Mesirow Financial Investment Management Inc. Has $16.08 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Assetmark Inc. Buys 18,265 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
7,322 Shares in Zoetis Inc. (NYSE:ZTS) Acquired by CWA Asset Management Group LLC - MarketBeat
Summit Global Investments Acquires 4,010 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Principal Financial Group Inc. Raises Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Job Fair Thursday (11.07) at Zoetis in Charles City - KCHA News
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):